Unlock instant, AI-driven research and patent intelligence for your innovation.

A nanoscale carrier protein platform for enhancing antigen immunogenicity

A technology of antigen immunization and carrier protein, which is applied in the direction of carrier-binding antigen/hapten components, antibody medical components, and resistance to vector-borne diseases. It can solve problems such as increasing HDL-C degradation and research in the field of vaccine nanotechnology. Achieve the effect of enhancing immunity and facilitating recognition

Active Publication Date: 2020-02-21
XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no literature to directly study the direct relationship between PCSK9 vaccine and atherosclerosis, because APOE will bind to LDLR and increase the degradation of HDL-C
There is currently no nanoscale research on this vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A nanoscale carrier protein platform for enhancing antigen immunogenicity
  • A nanoscale carrier protein platform for enhancing antigen immunogenicity
  • A nanoscale carrier protein platform for enhancing antigen immunogenicity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment one, the preparation of OVA nano material

[0055] The specific method is as follows:

[0056] Step 1. Dissolving OVA molecules in ddH 2 After O, the mass concentration of the solution is 10mg / ml;

[0057] Step 2, take 2.5ml of the above OVA solution in a 5ml reaction bottle (containing a matching magnet), add 2.5ml of Mes (PH=6.0) buffer and mix;

[0058] Step 3. Put the water bath in a magnetic stirrer, heat it to 70°C, adjust the speed to 750r, put the above reaction bottle in the water bath, and let it fully heat for 2min10s;

[0059] Step 4, the product is dialyzed (ddH 2 (O 5L, change the water every 2 hours, 5 times in total), and freeze-dry to obtain OVA nanomaterials (OVA-NP) with an average particle size of 50nm.

[0060] In the preparation process of the OVA nanomaterial, according to the difference of the target particle size, the reaction time, the concentration of the reaction, the rotation speed and the number of dialysis after the post-tre...

Embodiment 2

[0077] Embodiment two, the preparation of nano vaccine

[0078] The specific preparation formula of the nano vaccine is as follows:

[0079]

[0080] Program A.peptide for CETP 471-476 The specific preparation process of the nano vaccine is as follows:

Embodiment A-1

[0082] Step 1, configuration of reaction solvent:

[0083] Reaction solution A: Dissolve OVA-NP in PBS (pH=7.2, 0.01M), and configure a solution with a mass concentration of 2 mg / ml;

[0084] Reaction solution B: Dissolve NEM in PBS (pH=7.2, 0.01M), and prepare a solution with a mass concentration of 0.6256 mg / ml;

[0085] Reaction solution C: dissolve sulfo-smcc in ddH 2 O, configuration mass concentration is the solution of 4.8mg / ml;

[0086] Reaction solution D: CETP 471-476 (Customized synthesis by Jill Biochemical Company, with a cysteine ​​added at the amino terminal) dissolved in DMF or DMSO, and a solution with a mass concentration of 25mg / ml was prepared;

[0087] Step 2, take 2ml of solution A and 1.078ml of solution B, and react for 2 hours at room temperature at a speed of 400r / min;

[0088] Step 3: Add 0.164ml of solution C, and react for 1 hour at room temperature at a speed of 400r / min;

[0089] Step 4, use 3K ultrafiltration tube, secondary water, 4500r*20...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a nano-carrier protein platform capable of improving antigen immunogenicity. The nano-carrier protein platform capable of improving antigen immunogenicity is characterized in that a target is connected to the surfaces of nano-carrier proteins so as to improve antigen immunogenicity, wherein the nano-carrier proteins refer to nano-particles manufactured from carrier proteins. The nano-carrier protein platform capable of improving antigen immunogenicity has the advantages that peptide epitopes are displayed on the surfaces of the protein particles, and the protein particles provide T cell epitopes for the peptide epitopes and also serve as a nano-carrier to enable the peptide epitopes to have proper sizes, so that recognition and phagocytosis of antigen presenting cells are benefited; displaying B cell epitopes repeatedly is beneficial to B cell recognition, and accordingly immune effects can be enhanced.

Description

technical field [0001] The invention relates to the field of nano vaccines, in particular to a nano carrier protein platform for improving antigen immunogenicity. Background technique [0002] Existing studies have shown that low-density lipoprotein cholesterol (LDL-C) is a factor that promotes atherosclerosis, and high-density lipoprotein cholesterol (HDL-C) is an anti-atherosclerosis factor. Most of the research has been devoted to lowering LDL cholesterol and raising DDL cholesterol. [0003] Cholesteryl ester transfer protein (CETP, cholesteryl ester transfer protein) is a key protein that regulates cholesterol transport between HDL, LDL, and VLDL. Animal studies have shown that vaccines constructed with CETP polypeptides can reduce LDL-C, increase HDL-C, and have significant For the prevention of atherosclerosis, previous studies have confirmed that the 16 amino acid sequence CETP471-476 (FGFPEHLLVDFLQSLS) at the carboxyl terminal of the protein can be used in the deve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/00A61K39/385A61K47/64A61P3/06
CPCA61K39/00A61K39/385A61K2039/6081Y02A50/30
Inventor 何斌石学银尤纱纱李永勇董海青
Owner XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE